Latest News and Press Releases
Want to stay updated on the latest news?
-
Allegedly, defendants hid unauthorized FDA design changes to DexCom’s G6 and G7, making them less reliable and exposing users to health risks.
-
DexCom, Inc. investors that lost money are notified to contact BFA before the December 26, 2025 securities fraud class action deadline.
-
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
-
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and...
-
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of DexCom,...
-
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
-
The Complaint alleges DexCom made unauthorized G6 and G7 design changes, overstated reliability, and downplayed resulting health and regulatory risks.
-
LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises DexCom, Inc., (“DexCom” or the "Company") (NASDAQ: DXCM) investors off a class action on behalf of investors that bought...
-
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their...